Pregled bibliografske jedinice broj: 1198002
Albumin-to-globulin ratio as a potential predictor of renal remission in lupus nephritis
Albumin-to-globulin ratio as a potential predictor of renal remission in lupus nephritis // Annals of the rheumatic diseases, 80 (2021), Suppl 1
online, 2021. str. 1199-1199 doi:10.1136/annrheumdis-2021-eular.4111 (ostalo, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1198002 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Albumin-to-globulin ratio as a potential predictor
of renal remission in lupus nephritis
Autori
Knežević, Tamara ; Padjen, Ivan ; Bulimbašić, Stela ; Ćorić, Marijana ; Ivković, Vanja ; Laganović, Mario ; Anić, Branimir
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Annals of the rheumatic diseases, 80 (2021), Suppl 1
/ - , 2021, 1199-1199
Skup
European congress of rheumatolog (EULAR 2021)
Mjesto i datum
Online, 02.06.2021. - 05.06.2021
Vrsta sudjelovanja
Ostalo
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
albumin-to-globulin ratio ; lupus nephritis
Sažetak
Background: Optimal prognostic predictors in lupus nephritis (LN) are still not clearly defined. Studies have recently shown that albumin-to- globulin ratio (A/G) is not only a good predictor of outcomes in malignancy, infection and renal disease, but is also a potential marker of increased immunoglobulin synthesis and LN activity and might be useful as a predictor of the development of LN in SLE patients. Studies on the role of A/G in predicting outcomes in LN are, however, lacking. Objectives: To assess a potential prognostic value of A/G at renal biopsy in predicting outcomes in LN. Methods: In this retrospective study we analyzed the demographic, histologic, laboratory and clinical characteristics of patients with biopsy- proven LN diagnosed between 2011 and 2020. All patients met the 1997 revised American College of Rheumatology classification criteria for SLE. Complete remission was defined as proteinuria <0.5 g/day and serum creatinine within 10% from baseline, and partial remission as more than 50% reduction in proteinuria to sub-nephrotic levels and serum creatinine within 10% from baseline. Results: We have included 55 patients (80% women) with biopsy-proven LN (age at biopsy 38±13 years). On renal histology, one patient was class I LN, two patients were class II, 7 were class III, 5 were class III+V, 23 were class IV, two were class IV+V, 11 class VI and 4 had other features. Median eGFR and proteinuria at biopsy were 69 (IQR: 44, 100) mL/min/1.73 m 2 and 3.5 (2.3, 5.6) g/day, respectively. Baseline mean A/G was 1.12±0.29 and did not differ between LN classes (p=0.91). At one-year follow-up eGFR increased non- significantly (69 vs. 82 mL/min/1.73 m 2 , p=0.13) and proteinuria decreased (3.5 vs. 0.6 g/day, p<0.001). Eighteen patients achieved complete remission (CR), 16 partial remission and 21 did not achieve remission. None progressed to ESRD and two patients died, both from sepsis. A/G at the time of biopsy did not differ between group which achieved CR/PR vs. no remission (p>0.05 ; Figure 1 ) and was not a significant predictor of remission in a multivariate regression model (OR 5.9, 95% CI 0.6, 63.2). Conclusion: While being a potential marker for transition of SLE to LN, A/G was not showed to be a predictor of renal remission in LN.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Tamara Knežević
(autor)
Branimir Anić
(autor)
Marijana Ćorić
(autor)
STELA BULIMBAŠIĆ
(autor)
Mario Laganović
(autor)
Vanja Ivković
(autor)
Ivan Padjen
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE